Terrie Curran Arcutis Biotherapeutics, Inc. (ARQT) insider trading activity

ARQT Quotes by TradingView

Terrie Curran is Director of Arcutis Biotherapeutics, Inc.. Currently has a direct ownership of 17,748 shares of ARQT, which is worth approximately $274,739. The most recent transaction as insider was on Jun 12, 2025, when has been sold 7,609 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 17.7K
75.05% 3M change
5.73% 12M change
Total Value Held $274,739

Terrie Curran Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 12 2025
BUY
Grant, award, or other acquisition
-
7,609 Added 30.01%
17,748 Common Stock
Nov 11 2024
SELL
Open market or private sale
$94,253 $10.85 p/Share
8,687 Reduced 46.14%
10,139 Common Stock
Jun 14 2024
BUY
Grant, award, or other acquisition
-
10,139 Added 35.0%
18,826 Common Stock
May 31 2023
BUY
Grant, award, or other acquisition
-
4,375 Added 33.49%
8,687 Common Stock
Jun 01 2022
BUY
Grant, award, or other acquisition
-
4,312 Added 50.0%
4,312 Common Stock

Also insider at

PHAT
Phathom Pharmaceuticals, Inc. Healthcare
President and Chief Executive
MYOV
Myovant Sciences Ltd. Healthcare
Director
TC

Terrie Curran

Director
Florham Park, NJ

Track Institutional and Insider Activities on ARQT

Follow Arcutis Biotherapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ARQT shares.

Notify only if

Insider Trading

Get notified when an Arcutis Biotherapeutics, Inc. insider buys or sells ARQT shares.

Notify only if

News

Receive news related to Arcutis Biotherapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ARQT